SOLODYN

Peak

minocycline hydrochloride

NDAORALTABLET, EXTENDED RELEASE
Approved
May 2006
Lifecycle
Peak
Competitive Pressure
0/100
Clinical Trials
1

Clinical Trials (1)

NCT02297412Phase 2Completed

Minocycline Hydrochloride in Reducing Chemotherapy-Induced Peripheral Neuropathy and Acute Pain in Patients With Breast Cancer Undergoing Treatment With Paclitaxel

Started Nov 2014
47 enrolled
Acute PainBreast CarcinomaPeripheral Neuropathy

Loss of Exclusivity

LOE Date
Nov 17, 2031
69 months away
Patent Expiry
Nov 17, 2031

Patent Records (4)

Patent #ExpiryTypeUse Code
7919483
Mar 7, 2027
U-1078
7541347
Apr 2, 2027
U-917
7544373
Apr 2, 2027
Product
9192615
Nov 17, 2031
Product